A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes

被引:198
作者
Sharma, Sreenath V.
Gajowniczek, Patrycja
Way, Inna P.
Lee, Diana Y.
Jiang, Jane
Yuza, Yuki
Classon, Marie
Haber, Daniel A.
Settleman, Jeffrey
机构
[1] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
关键词
D O I
10.1016/j.ccr.2006.09.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncogene addiction describes an unexplained dependency of cancer cells on a particular cellular pathway for survival or proliferation. We report that differential attenuation rates of prosurvival and proapoptotic signals in oncogene-dependent cells contribute to cell death following oncogene inactivation. Src-, BCR-ABL-, and EGF receptor-dependent cells exhibit a similar profile of signal attenuation following oncogene inactivation characterized by rapid diminution of phospho-ERK, -Akt, and -STAT3/5, and a delayed accumulation of the proapoptotic effector phospho-p38 MAPK. These findings implicate a transient imbalance in survival and apoptotic oncogenic outputs in the apoptotic response to oncogene inactivation. Moreover, these observations implicate a common profile of signal attenuation for multiple oncogenes and suggest that "addiction" associated with apoptosis reflects an active rather than a passive process.
引用
收藏
页码:425 / 435
页数:11
相关论文
共 39 条
[1]  
Aoki K, 1997, MOL CARCINOGEN, V20, P251, DOI 10.1002/(SICI)1098-2744(199710)20:2<251::AID-MC12>3.3.CO
[2]  
2-P
[3]   Janus faces of ras:: anti or pro-apoptotic? [J].
Arber, N .
APOPTOSIS, 1999, 4 (05) :383-388
[4]   Chlorogenic acid-inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells [J].
Bandyopadhyay, G ;
Biswas, T ;
Roy, KC ;
Mandal, S ;
Mandal, C ;
Pal, BC ;
Bhattacharya, S ;
Rakshit, S ;
Bhattacharya, DK ;
Chaudhuri, U ;
Konar, A ;
Bandyopadhyay, S .
BLOOD, 2004, 104 (08) :2514-2522
[5]   SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling [J].
Blake, RA ;
Broome, MA ;
Liu, XD ;
Wu, JM ;
Gishizky, M ;
Sun, L ;
Courtneidge, SA .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (23) :9018-9027
[6]   Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers [J].
Brunet, CL ;
Gunby, RH ;
Benson, RSP ;
Hickman, JA ;
Watson, AJM ;
Brady, G .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (01) :107-115
[7]   Essential role for oncogenic Ras in tumour maintenance [J].
Chin, L ;
Tam, A ;
Pomerantz, J ;
Wong, M ;
Holash, J ;
Bardeesy, N ;
Shen, Q ;
O'Hagan, R ;
Pantginis, J ;
Zhou, H ;
Horner, JW ;
Cordon-Cardo, C ;
Yancopoulos, GD ;
DePinho, RA .
NATURE, 1999, 400 (6743) :468-472
[8]   Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].
Druker, BJ ;
Tamura, S ;
Buchdunger, E ;
Ohno, S ;
Segal, GM ;
Fanning, S ;
Zimmermann, J ;
Lydon, NB .
NATURE MEDICINE, 1996, 2 (05) :561-566
[9]   Reversible tumorigenesis by MYC in hematopoietic lineages [J].
Felsher, DW ;
Bishop, JM .
MOLECULAR CELL, 1999, 4 (02) :199-207
[10]   Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL(+) leukemic cells and induces apoptosis [J].
GambacortiPasserini, C ;
leCoutre, P ;
Mologni, L ;
Fanelli, M ;
Bertazzoli, C ;
Marchesi, E ;
DiNicola, M ;
Biondi, A ;
Corneo, GM ;
Belotti, D ;
Pogliani, E ;
Lydon, NB .
BLOOD CELLS MOLECULES AND DISEASES, 1997, 23 (19) :380-394